PLDT Inc.
PLDT Inc. (PHI) Financial Performance & Income Statement Overview
Analyze PLDT Inc. (PHI) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
PLDT Inc. (PHI) Income Statement & Financial Overview
Analyze PLDT Inc.’s PHI earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $55.89B | $53.36B | $53.36B | $54.22B |
| Cost of Revenue | $7.61B | $6.73B | $6.65B | $18.44B |
| Gross Profit | $48.28B | $46.63B | $46.71B | $35.78B |
| Gross Profit Ratio | $0.86 | $0.87 | $0.88 | $0.66 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $10.42B | $18.99B | $20.47B | $18.75B |
| Operating Expenses | $38.40B | $46.63B | $20.47B | $20.18B |
| Total Costs & Expenses | $46.007B | $53.36B | $27.12B | $38.62B |
| Interest Income | $198.00M | $0.00 | $859.00M | $0.00 |
| Interest Expense | $4.50B | $0.00 | $4.38B | $0.00 |
| Depreciation & Amortization | $18.89B | $12.94B | $7.29B | $11.70B |
| EBITDA | $29.03B | $27.70B | $20.90B | $27.30B |
| EBITDA Ratio | $0.52 | $0.52 | $0.39 | $0.50 |
| Operating Income | $9.88B | $0.00 | $26.24B | $15.60B |
| Operating Income Ratio | $0.18 | $0.00 | $0.49 | $0.29 |
| Other Income/Expenses (Net) | -$4.25B | $12.76B | -$15.13B | -$2.41B |
| Income Before Tax | $5.63B | $12.76B | $11.11B | $13.59B |
| Income Before Tax Ratio | $0.10 | $0.24 | $0.21 | $0.25 |
| Income Tax Expense | $1.30B | $3.05B | $2.49B | $3.30B |
| Net Income | $4.24B | $9.66B | $8.59B | $9.82B |
| Net Income Ratio | $0.08 | $0.18 | $0.16 | $0.18 |
| EPS | $19.51 | $44.63 | $39.62 | $45.40 |
| Diluted EPS | $19.55 | $44.71 | $39.69 | $45.40 |
| Weighted Avg Shares Outstanding | $216.40M | $216.40M | $216.40M | $216.06M |
| Weighted Avg Shares Outstanding (Diluted) | $216.00M | $216.00M | $216.00M | $216.06M |
Financial performance has remained strong, with revenue growing from $54.22B in Q1 2024 to $55.89B in Q4 2024. Gross profit continued to perform well, with margins at 86% in the latest quarter. Operating income reached $9.88B in Q4 2024, holding a steady 18% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at $29.03B. Net income dropped to $4.24B, keeping EPS at $19.51. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan